Catherine Copley‐Merriman

Model of Complications of NIDDM: II. Analysis of the health benefits and cost-effectiveness of treating NIDDM with the goal of normoglycemia

Richard C. Eastman, Jonathan C. Javitt, William H. Herman et al. · Diabetes Care · 1997 · 337 citations

Model of Complications of NIDDM: I. Model construction and assumptions

Richard C. Eastman, Jonathan C. Javitt, William H. Herman et al. · Diabetes Care · 1997 · 259 citations

Multiple Co-primary Endpoints: Medical and Statistical Solutions: A Report from the Multiple Endpoints Expert Team of the Pharmaceutical Research and Manufacturers of America

Walter Offen, Christy Chuang‐Stein, Alex Dmitrienko et al. · Drug Information Journal · 2007 · 122 citations · Full text

Medicine, Clinical Endpoint, Outcomes Research +8

High burden and unmet patient needs in chronic kidney disease

V. Sood, Braun, Hogue et al. · International Journal of Nephrology and Renovascular Disease · 2012 · 89 citations · Full text

Health‐related quality of life and symptoms in patients with myelofibrosis treated with ruxolitinib <i>versus</i> best available therapy

Claire Harrison, Ruben A. Mesa, Jean‐Jacques Kiladjian et al. · British Journal of Haematology · 2013 · 88 citations · Full text